Clinical Trials

Showing trials with last updates posted in 2025.

NCT02473380 | COMPLETED | PHASE1
11 participants

Fluorescence Spectroscopy Guided Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2015-08-31
Completion:
2016-10-31
Conditions
  • Low Grade Glioma (LGG)
  • High Grade Glioma (HGG)
Interventions
  • DEVICE
No Results Yet
NCT02201992 | ACTIVE_NOT_RECRUITING | PHASE3
166 participants

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2015-03-23
Completion:
2036-05-01
Conditions
  • ALK Gene Rearrangement
  • ALK Gene Translocation
  • ALK Positive
  • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
  • Stage II Non-Small Cell Lung Cancer AJCC v7
  • Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
  • Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
  • Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Interventions
  • OTHER
  • DRUG
No Results Yet
NCT02050750 | ACTIVE_NOT_RECRUITING
600 participants

TAILORx Tissue Bank

Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2013-12-31
Completion:
2020-12-31
Conditions
  • Breast Cancer
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page